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Background: Secondary infections are the leading cause of death in patients with severe acute pancreatitis (SAP).
The gut represents the main source of pancreatic contamination and related septic complications. High-mobility
group box chromosomal protein 1 (HMGB1) was recently identified to play an important role in the SAP intestinal
mucosal barrier dysfunction.
Objective: To investigate the correlation of high-mobility group box 1 (HMGB1) with intestinal barrier injury and
infections in patients with severe acute pancreatitis (SAP).
Methods: The serum levels of HMGB1, amylase, lipase, and biochemical indicators were measured in 80 patients
with SAP at the time of admission. Furthermore, relationship between their serum HMGB1 levels and intestinal
barrier injury, infection and other clinical factors were analyzed.
Results: The mean value of serum HMGB1 levels was significantly higher in patients with SAP (6.02 ± 2.42 ng/mL)
than that in healthy volunteers (1.87 ± 0.63 ng/mL). Serum HMGB1 levels were significantly positively correlated
with the Ranson score. The HMGB1 levels were higher in patients with infection during the clinical course, the
HMGB1 levels in non-survivors were higher than those in survivors, and positively correlated with DAO activity,
L/M ratio, the concentration of endotoxin (R = 0.484, P <0.01).
Conclusions: HMGBl level of patients with severe acute pancreatitis was significantly increased, and can be used as
an important indicator to determine the intestinal barrier dysfunction and infection.
Keywords: Severe acute pancreatitis, Intestinal mucosal barrier, Injury, High-mobility group box chromosomal protein 1
(HMGB1), Inflammation, InfectionSevere acute pancreatitis (SAP) has high mortality, but
multiple and timely interventions can improve survival
[1]. In patients with SAP, SIRS-related gut hypoperfusion
and mucosal damage may occur early, and may contribute
to clinical worsening. It has been showed that in SAP early
gut mucosal damage severity correlates with clinical
severity, as well as with the development of secondary
infections [2].* Correspondence: zhangweijie1616@163.com
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unless otherwise stated.High-mobility group box chromosomal protein 1
(HMGB1), originally discovered as a nuclear DNA-binding
protein, was recently identified as a potent proinflammatory
and late-acting mediator of endotoxin lethality [3].
Experimental models of SAP identified HMGB1 as a
key contributor to gut barrier dysfunction, and found a
significant correlation between HMGB1 serum levels and
the severity of intestinal mucosal injury [4].
In clinical studies of SAP, HMGB1 acts as an early
marker of disease worsening, by reflecting pancreatic
tissue injury and inflammation. Serum levels of HMGB1
of SAP patients on admission are significantly higher than
in healthy controls, and significantly correlate with theis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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between HMGB1 and gut mucosal injury has not been
investigated in a clinical setting.
In this study, we aim to clarify whether HMGB1 is
correlated with intestinal mucosal barrier injury and
infection of SAP; and the relationships between their
serum HMGB1 levels and various clinical factors for
SAP were also analyzed.
Materials and methods
Patients and samples
Serum samples were obtained from 10 healthy volunteers
and patients with SAP in our department between October
2003 and April 2007. Only patients at the time of admission
within the initial 72 hours was admitted. The samples were
stored at -80°C until they were assayed. The diagnosis of
acute pancreatitis requires two of the following three
features: (1) abdominal pain consistent with acute pancrea-
titis (acute onset of a persistent, severe, epigastric pain often
radiating to the back); (2) serum lipase activity (or amylase
activity) at least three times greater than the upper limit of
normal; and (3) characteristic findings of acute pancreatitis
on contrast-enhanced computed tomography (CECT)
and less commonly magnetic resonance imaging (MRI) or
transabdominal ultrasonography [6].
The classification defines three degrees of severity: mild
acute pancreatitis, moderately severe acute pancreatitis,
and severe acute pancreatitis [6,7]. Terminology that is
important in this classification includes transient organ
failure, persistent organ failure, and local or systemic
complications (Table 1) [6]. Transient organ failure is
organ failure that is present for <48 h. Persistent
organ failure is defined as organ failure that persists
for >48 h.
The presence of infection can be presumed when there
is extraluminal gas in the pancreatic and/or peripancreatic
tissues on CECT or when percutaneous, image-guided,
fine-needle aspiration (FNA) is positive for bacteria
and/or fungi on Gram stain and culture [8].Table 1 Grades of severity of acute pancreatitis
Mild acute pancreatitis
▸ No organ failure
▸ No local or systemic complications
Moderately severe acute pancreatitis
▸ Organ failure that resolves within 48 h (transient organ failure) and/or
▸ Local or systemic complications without persistent organ failure
Severe acute pancreatitis
▸ Persistent organ failure (>48 h)
– Single organ failure
– Multiple organ failure
Ref [6] Banks PA, et al. Gut. 2013; 62(1):102-111.The following baseline and outcome variables were
recorded for each patient on admission: age, gender,
etiology, the coexisting condition, acute physiology and
chronic health evaluation II (APACHE II) score, Ranson
score (>3 as high and ≤ 3 as low Ranson group), CT se-
verity index (CTSI)-which is a 10-point scoring system
derived by assessing the degree of pancreatic and peri-
pancreatic inflammation (0 to 2 points), the presence
and number of peripancreatic fluid collections (0 to 2
points), and the presence and degree of pancreatic par-
enchymal non-enhancement or necrosis (0 to 6 points)
[9], the extent of pancreatic necrosis, the multiple organ
dysfunction score (MODS), the mortality, and the length
of hospital stay. The following items were also recorded
at enrollment: the CECT before study entry; leukocyte
count and neutrophil percentage; blood biochemical pa-
rameters, such as: the serum levels of C-reactive protein
(CRP), amylase, procalcitonin (PCT), and HMGB1 were
all evaluated. The serum HMGB1 levels were deter-
mined, and the relationships with sex, etiology, pancre-
atic necrosis, severity, blood biochemical parameters on
admission, organ dysfunction and infection during the
clinical course, and prognosis were also analyzed.
The study was approved by the ethics committees of
the Nanjing Drum Tower Hospital and informed con-
sent was obtained from each patient.
Serum concentrations of high-mobility group box
chromosomal protein 1
HMGB1 was measured by the commercially available
HMGB1 ELISA Kit II (SHINO-TEST Corporations,
Kanagawa, Japan) [10]. Briefly, in the wells coated with
anticalf HMGB1 monoclonal antibody, samples to be
measured or standards are incubated for 24 hours at
37°C. After washing the well for 5 times, a peroxidase-
conjugated anti-HMGB1 monoclonal antibody was
added into the microwell and incubated for 120 minutes
at room temperature. After washing the well for 5 times,
100 KL of luminogen was added into the microwell and
incubated for 30 minutes at room temperature. A stop
solution was added to each well to terminate the enzyme
reaction and to stabilize the developed color. The optical
density of each well was measured at 450 nm using a
microplate reader. The results were calculated using a
calibration curve prepared from standards.
The plasma diamine oxidase (DAO) activity
DAO activity was assayed according to the modified
method of Nobumichi et al. [11]. In the final volume of
3.8 ml, the assay mixture contained 3ml of phosphate
buffer (0.2 M, pH 7.2), 0.1 ml (4 μg) of horseradish per-
oxidase solution (Sigma), 0.1 ml of o-dianisidine metha-
nol solution (500μg of o-dianisidine purchased), 0.5 ml
plasma; 0.1 ml of substrate solution (175 μg of
Table 2 The clinical features, etiology, severity and
clinical outcomes of the patients with SAP





Diabetes mellitus 7 8.8
Hypertension 9 11.3
Chronic kidney disease 5 6.3
Other 9 11.3


















Secondary infections 23 28.8
MODS 60 75
Mortality 15 18.8
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incubated for 30 min at 37°C, and DAO activity was
measured as the absorbance at 436 nm.
Intestine mucosal permeability
This was assessed by the lactulose–mannitol (L/M) ratio in
urine. Patients were administered orally 60 ml solution
(consisting of 10 g lactulose and 5 g mannitol) after evacu-
ating the urinary bladder in the morning, and their urine
was collected for the subsequent 6 h. During this period
the patients were not permitted any oral intake of food or
water. The urine volume was measured and the concentra-
tion of lactulose and mannitol were determined according
to the method of Sörensen and Proud [12].
The plasma endotoxin level
This was detected by the end-point chromogenic method
based on the activation of a limulus amoebocyte lysate.
Heparin sodium (20U) was added to each blood sample
(3ml), and centrifuged at 300 rpm/min for 10 min to obtain
plasma. Each sample was diluted at 1:4 with pyrogen-free
water and heated at 100°C for 8 min to inhibit the interfere
factors with limulus assay. The manipulation was done
according to the instructions in the kits provided by Sigma.
Statistical analysis
Statistical analysis was performed using SPSS version
16.0 software (SPSS, Inc., Chicago, IL, U.S.A.). Unless
test for normality of data distribution has been made, the
results are given as medians with ranges and interquartile
ranges (IQR). For comparison of the two groups, χ2-analysis
or Fisher’s exact test were used when appropriate for
qualitative data, and Student’s t-test for quantitative
data. Pearson correlation analysis was performed to
assess the correlations between HMGB1 and the continu-
ous variables, and Spearman correlation was performed to
assess the correlations between HMGB1 and the non-




The study group consisted of 80 patients with (47
men and 33 women). A total of 80 SAP patients were
included in this study. Forty-eight patients (58.8%)
were male, and the median age of the patients was 43
years (19–89 years). The median time interval between
onset and admission was 32 hours (2–71 hours). The level
of serum amylase was 1900 U/L (430-3100 U/L). The CRP
and PCT level was 11.73 mg/dL (0.79-44.08 mg/dL) and
4.28 ng/mL (0.01-166.69 ng/mL), respectively. The
median length of hospital stay was 20 days (13-64 days),
and the mortality rate was 15 out of 80 patients (18.8%).The clinical characteristics, etiology, severity and clinical
outcomes of patients were in Table 2.
Serum high-mobility group box chromosomal protein 1
levels in patients with severe acute pancreatitis
The mean value of serum HMGB1 levels in patients with
SAP at the time of admission (within 72 hours after the
onset) was 6.02 ± 2.42 ng/mL and was significantly
higher than that in healthy subjects (1.87 ± 0.63 ng/mL).
Relationship with blood biochemical parameters on
admission
Correlation efficient of serum HMGB1 levels with
various blood biochemical parameters on admission was
investigated. Procalcitonin, total bilirubin and C-reactive
protein were significantly positively correlated with serum
Table 3 The Intestine mucosal barrier function between






(n = 10) (n = 80)
DAO (IU/ml) 0.370 ± 0.16 3.45 ± 1.67 <0.001
L/M 0.03 ± 0.01 0.26 ± 0.09 <0.001
Endotoxin (EU/ml) 0.0870 ± 0.019 0.3613 ± 0.16 0.01
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find the significant correlation between other parameters
(amylase, etc.) and serum HMGB1 levels. The value
of HMGB1 versus amylase, lipase, ALT, and AST was
R= 0.118, P= 0.297; R = 0.175, P= 0.120; R = 0.122 p = 0.286,
and R= 0.156 p = 0.174, respectively.
Relationship with severity score on admission
Serum HMGB1 levels were positively correlated with
Ranson score (R = 0.297; Figure 2A) and were significantly
higher in the high Ranson score group (6.1 ± 2.6 ng/mL)
than those in the low Ranson score group (5.8 ± 1.1 ng/mL),
(p = 0.032 Figure 2B), whereas serum HMGB1 levels
were not correlated with CT severity index (R = 0.017)
or APACHE II score (R = 0.058).
Relationship with intestine mucosal barrier function
The plasma DAO activity and serum endotoxin levels
were significantly higher were significantly higher in
patients with SAP than that of healthy control (P < 0.01).
The urinary lactulose concentrations were significantly
higher in SAP patients than in healthy controls (P < 0.01).
There is no significant difference in mannitol excretionFigure 1 Correlation of serum high-mobility group box chromosomal
in patients with severe acute pancreatitis.between two groups. The lactulose to mannitol ratio in
the SAP group is significantly higher than that of healthy
groups (P < 0.01) (Table 3).
Correlation efficient of serum HMGB1 levels with
intestinal mucosal barrier parameters on admission
was investigated, and found that plasma DAO activity,
serum endotoxin, urinary lactulose and mannitol ratio
(L/M) were significantly positively correlated with
serum HMGB1 levels (R = 0.484, P < 0.01, Figure 3).
Relationship between infection during hospitalization
with the intestine mucosal barrier
The plasma DAO activity, serum endotoxin and lactulose
to mannitol ratio levels were higher in patients with infec-
tion (2.90 ± 1.37 and) than those without infection, but only
serum endotoxin (0.33 ± 0.13 vs 0.44 ± 0.21, p = 0.001) was
significant higher, the plasma DAO activity (2.90 ± 1.37 vs
4.82 ± 1.57, p = 0.234) and L/M (0.23 ± 0.07 vs 0.34 ± 0.08,
p = 0.275) were not significant.
Relationship with infection during hospitalization and
prognosis
Serum HMGB1 levels in patients with infection
(8.9 ± 2.47 ng/mL) were significantly higher than those in
patients without infection (4.9 ± 1.04 ng/mL). Serum
HMGB1 levels in non-survivors (9.7 ± 2.68 ng/mL) were
higher than those in survivors (5.2 ± 1.3 ng/mL), but there
was no significant difference (Figure 4).
Discussion
In this study, we evaluated serum HMGB1 concentrations
in 80 patients with SAP and compared them to the
concentrations in healthy control subjects. Furthermore,protein 1 levels with blood biochemical parameters on admission
Figure 2 A, Correlation of serum HMGB1 levels with Ranson scores on admission. B, A comparison between serum levels of HMGB1 in
high (>3) and low (<3) Ranson score groups.
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biochemical parameters, intestinal mucosa barrier, and
infections in patients with SAP were also analyzed.
We identified that the concentration of serum HMGB1
was higher in patients with SAP than in normal healthy
subjects, and it can be used as an important indicator to
determine the intestinal barrier dysfunction and infection
in clinical setting.
Blood biochemical parameters, such as C-reactive
protein (CRP) and procalcitonin (PCT) have been
considered to evaluate the evolution of infections and
sepsis in critically ill patients. However, both proteins are
also induced during non-infectious causes of systemic
inflammation and in patients with organ dysfunction[13]. Total bilirubin combined with serum glutamate
oxaloacetic transaminase (AST) or glutamate pyruvic
transaminase (ALT) are predicators of liver dysfunction,
especially in biliary acute pancreatitis. In the results
obtained, we have demonstrated that serum HMGB1
levels were significantly positively correlated with PCT,
CRP and total bilirubin on admission. These results
suggest that HMGB1 may be closely related to the aggrava-
tion of SAP in the early phase and that increase of serum
HMGB1 may reflect tissue injury and inflammation.
DAO is found almost exclusively in the small intestine,
its activity is closely correlated with villi height, nucleic
acid, and protein synthesis of intestinal mucosal cells.
The intestinal tissue and serum levels of DAO have been
Figure 3 Correlation efficient of serum HMGB1 levels with intestinal mucosal barrier parameters (plasma DAO activity, serum
endotoxin, urinary L/M ratio).
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of the intestinal mucosa, and also lactulose/mannitol
seems to be an inexpensive and quite reliable method
for interpreting ntestinal permeability. In this study, we
found the activity of plasma DAO; the levels of plasma
endotoxin and urinary L/M ratio were all elevated
markedly, and this phenomenon was found in patients
with infection, but only serum endotoxin was significant
higher than those without infection.
HMGB1 act as a late-acting mediator of development of
ileal mucosal hyperpermeability and increased bacterial
translocation, promotes alterations in gut barrier function
by increasing the permeability in enterocytic monolayers
and increasing bacterial translocation to lymph nodes
[14]. It has been suggested that stabilization of intestinal
integrity reduced pancreatic infections in experimentalFigure 4 Relationship of serum HMGB1 levels with infection and prog
and Methods.and clinical pancreatitis, breakdown of the gut mucosal
barrier resulted in the passage of luminal bacteria and
endotoxin into the systemic circulation [2,4,15]. Therefore,
improvement of increased gut permeability is a key step
for control of the infectious complications. Rats with SAP
showed an increased intestinal permeability when
compared with the controls, and the subsequent endotoxin
translocation was also confirmed [16]. Consistent with our
observations, we observed HMGB1 levels were higher in
patients with secondary infection and non-survivors during
the clinical course. We have also obtained that the HMGB1
levels were higher in patients with intestinal mucosal
barrier injury for the first time. The curculated HMGB1
concentrations were remarkably increased in patients with
SAP and correlated with the severity of intestinal barrier
dysfunction. Results obtained here with these observationsnosis. Infection was defined as described under Materials
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phase may be useful as a new therapeutic option against
the inflammation and gut mucosal injury in SAP [17].
In this study, we have shown that serum HMGB1
levels were significantly increased in patients with SAP, and
for the first time in clinical setting, we found circulating
HMGB1 were correlated with the severity of intestinal bar-
rier dysfunction. Such results give direct evidence HMGB1
might be the key factor causing morphologic destruction of
small intestinal mucosal barrier. These results suggest that
HMGB1 may play a pivotal role in the pathogenesis of SAP
and that HMGB1 may act as a promoter and early marker
of gut mucosal injury.
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